#Analysts weigh in on #FDA’s #approval for #Amgen’s #small cell #cancer #drug :
The #usa Food and Drug Administration (FDA) on Thursday granted accelerated approval to Amgen’s (NASDAQ:#AMGN) new drug, tarlatamab, marketed as Imdelltra, for the treatment of adults with advanced small cell lung cancer. The approval is specifically for cases that have progressed following chemotherapy treatments. Imdelltra is a bispecific antibody therapy that works by connecting […]
#Analysts weigh in on #FDA’s #approval for #Amgen’s #small cell #cancer #drug : Read More »